摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-hydroxy-3-methyl-butanyl pyrophosphate | 102186-02-7

中文名称
——
中文别名
——
英文名称
3-hydroxy-3-methyl-butanyl pyrophosphate
英文别名
diphosphoric acid mono-(3-hydroxy-3-methyl-butyl) ester;3-Hydroxy-3-methyl-butyl-(1)-pyrophosphat;(3-Hydroxy-3-methylbutyl) phosphono hydrogen phosphate
3-hydroxy-3-methyl-butanyl pyrophosphate化学式
CAS
102186-02-7
化学式
C5H14O8P2
mdl
——
分子量
264.109
InChiKey
RZFCFDAITMFIMJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.4
  • 重原子数:
    15
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    134
  • 氢给体数:
    4
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    3-羟基-3-甲基对甲苯磺酸丁酯tris(tetra-n-butylammonium) hydrogen pyrophosphate 作用下, 以50%的产率得到3-hydroxy-3-methyl-butanyl pyrophosphate
    参考文献:
    名称:
    Mutation and inhibition studies of mevalonate 5-diphosphate decarboxylase
    摘要:
    Mevalonate 5-diphosphate decarboxylase plays an important role in regulating cholesterol biosynthesis, which was studied through incubation with various synthetic substrate analogs and characterization of mutated enzymes. The results are potentially useful for further developing inhibitors that block the mevalonate pathway which is a drug target for treating cardiovascular disease and cancer. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.09.033
点击查看最新优质反应信息

文献信息

  • Machleidt,H. et al., Justus Liebigs Annalen der Chemie, 1964, vol. 672, p. 215 - 222
    作者:Machleidt,H. et al.
    DOI:——
    日期:——
  • Mutation and inhibition studies of mevalonate 5-diphosphate decarboxylase
    作者:Yongge Qiu、Jinbo Gao、Fei Guo、Yuqin Qiao、Ding Li
    DOI:10.1016/j.bmcl.2007.09.033
    日期:2007.11
    Mevalonate 5-diphosphate decarboxylase plays an important role in regulating cholesterol biosynthesis, which was studied through incubation with various synthetic substrate analogs and characterization of mutated enzymes. The results are potentially useful for further developing inhibitors that block the mevalonate pathway which is a drug target for treating cardiovascular disease and cancer. (C) 2007 Elsevier Ltd. All rights reserved.
查看更多